Moderna in talks with FDA over Phase 4 Covid vaccine data
Moderna said it's working with US regulators to provide post-marketing data on its Covid-19 vaccines that could restore their use to a wider group after FDA leaders narrowed the label for the products last year. ...
Photo: Kyle LaHucik for Endpoints News May 1, 2026 02:08 PM EDTUpdated 02:44 PM R&DPharmaFDA+Coronavirus Moderna in talks with FDA over post-marketing Covid shot data, with eyes on wider access Max Bayer Senior Reporter Moderna said it’s working with US regulators to provide post-marketing data on its Covid-19 vaccines that could restore their use to a wider group after … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER
comments(0)
5-min edit window · permanent after that